GlassScriptPhysician profile
Andre B Akhondi
NPI 1205000890
$20,175.44
in general payments reported to CMS, 2019-2025
19 companies · $4,439 in 2025
The $4,439 reported for 2025 was more than what 91% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,822 · 2020: $3,288 · 2021: $3,079 · 2022: $2,775 · 2023: $2,816 · 2024: $1,957 · 2025: $4,439.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,806 · Travel and Lodging: $1,373 · Debt Forgiveness: $32.58.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,806.24 |
| Travel and Lodging | $1,373.24 |
| Debt Forgiveness | $32.58 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $7,558.99 | 2020-2025 | Pressurewire, Dragonfly Opstar, Coroflow |
| Edwards Lifesciences Corporation | $5,196.60 | 2019-2024 | Sapien 3 Ultra Resilia, Edwards Sapien 3 Transcatheter Heart Valve (Thv), Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Impulse Dynamics (USA) INC. | $2,467.22 | 2025 | Optimizer |
| Medtronic, INC. | $2,239.17 | 2022-2025 | Corevalve Evolut R, Affera Mapping System, Selectsecure |
| Medtronic Vascular, INC. | $1,341.77 | 2019-2020 | |
| Shockwave Medical, INC | $217.69 | 2023 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Corindus INC. | $183.08 | 2019 | |
| Boston Scientific Corporation | $180.13 | 2025 | Emerge Push, Lux-Dx Insertable Cardiac Monitor |
| Irhythm Technologies, INC. | $162.15 | 2022 | |
| Cardiovascular Systems INC. | $144.53 | 2019 | |
| Janssen Pharmaceuticals, INC | $123.03 | 2024 | Xarelto |
| Biosense Webster, INC. | $108.35 | 2025 | Carto 3 |
| Biotronik INC. | $90.85 | 2021-2023 | Edora 8 Dr-T |
| Abiomed | $49.64 | 2025 | |
| Baxter Healthcare | $32.58 | 2024 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $26.62 | 2024 | Lifevest |
| Novartis Pharmaceuticals Corporation | $23.73 | 2019 | |
| Cardiva Medical, INC. | $15.74 | 2023 | Cardiva Vascade Mvp Vvcs 6-12f |
| Ekos Corporation | $13.57 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andre Akhondi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.